Pvg Asset Management Corp Bio Line Rx Ltd. Transaction History
Pvg Asset Management Corp
- $19.7 Million
- Q4 2023
A detailed history of Pvg Asset Management Corp transactions in Bio Line Rx Ltd. stock. As of the latest transaction made, Pvg Asset Management Corp holds 61,840 shares of BLRX stock, worth $52,564. This represents 0.49% of its overall portfolio holdings.
Number of Shares
61,840Holding current value
$52,564% of portfolio
0.49%Shares
7 transactions
Others Institutions Holding BLRX
# of Institutions
35Shares Held
1.43MCall Options Held
24.1KPut Options Held
184K-
Morgan Stanley New York, NY291KShares$247,6500.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA205KShares$174,1760.0% of portfolio
-
Values First Advisors, Inc.204KShares$173,1950.07% of portfolio
-
Lpl Financial LLC Fort Mill, SC100KShares$85,2740.0% of portfolio
-
Atria Wealth Solutions, Inc. New York, NY99.3KShares$84,4330.0% of portfolio
About BioLineRx Ltd.
- Ticker BLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,524,500
- Market Cap $52.3M
- Description
- BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials ...